Clinical Trials Logo

Clinical Trial Summary

Septic shock is still a major cause of death in ICU. Sepsis diagnosis is linked with many clinical, hemodynamic and biological criteria which have a low sensitivity and specificity if they are considered separately. The extensive experimental data which have been published contrast with the hematological data collected by the physician at patient's bedside especially regarding neutrophils and platelets levels. When there is no obvious clinical sign, a biological tool reflecting the patient's immune status could be useful to understand the physiopathology of Sepsis and to predict the progression of the disease in the patient. On the long-term it could also help to define management strategies.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01995448
Study type Observational
Source University Hospital, Limoges
Contact
Status Completed
Phase N/A
Start date November 2013
Completion date June 2015

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03113721 - Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis